Finafloxacin Patent Expiration
Finafloxacin is Used for treating acute external ear infections. It was first introduced by Fonseca Biosciences Llc
Finafloxacin Patents
Given below is the list of patents protecting Finafloxacin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xtoro | US9504691 | Finafloxacin suspension compositions | Nov 21, 2033 | Fonseca Biosciences |
| Xtoro | US8536167 | Methods for treating ophthalmic, otic, or nasal infections | Aug 08, 2031 | Fonseca Biosciences |
| Xtoro | US9119859 | Methods for treating otic infections | Jul 02, 2030 | Fonseca Biosciences |
| Xtoro | US9993483 | Compositions and methods for treating ophthalmic, octic, or nasal infections | Jul 02, 2030 | Fonseca Biosciences |
| Xtoro | US6133260 | Use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of Helicobacter pylori infections and associated gastroduodenal diseases |
Apr 12, 2017
(Expired) | Fonseca Biosciences |
| Xtoro | US6432948 | Use of 7-(2-oxa-5,8-diazabicylco[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of heliobacter pylori infections and associated gastroduodenal diseases |
Apr 12, 2017
(Expired) | Fonseca Biosciences |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Finafloxacin's patents.
Latest Legal Activities on Finafloxacin's Patents
Given below is the list recent legal activities going on the following patents of Finafloxacin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 06 May, 2024 | US9504691 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Feb, 2023 | US9119859 |
| Change in Power of Attorney (May Include Associate POA) Critical | 23 Nov, 2022 | US9993483 |
| Change in Power of Attorney (May Include Associate POA) Critical | 14 Nov, 2022 | US9119859 |
| Change in Power of Attorney (May Include Associate POA) Critical | 10 Nov, 2022 | US9504691 |
| Change in Power of Attorney (May Include Associate POA) Critical | 10 Nov, 2022 | US8536167 |
| Change in Power of Attorney (May Include Associate POA) Critical | 26 Oct, 2022 | US9993483 |
| Change in Power of Attorney (May Include Associate POA) Critical | 26 Oct, 2022 | US9504691 |
| Change in Power of Attorney (May Include Associate POA) Critical | 26 Oct, 2022 | US8536167 |
| Change in Power of Attorney (May Include Associate POA) Critical | 26 Oct, 2022 | US9119859 |
Finafloxacin's Family Patents
